Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Medical Software Market by Delivery mode (On-premises, Cloud-based), by Services (Client Relationship Management (CRM), Electronic Medical Records (EMR), Electronic Health Records (EHR), Medical Practice Management, Telemedicine, Population Health Management, Others) and by End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A10881

Pages: NA

Charts: NA

Tables: NA

Medical Software Market Outlook - 2027

Medical software is a combination of software that is used in performing and aiding in daily operation of healthcare services. The software has become an integral part of medical services management over the past few years as it assists the administration in efficient functioning. Medical software is extensively utilized for collection, storage, management and retrieval of patient data that is stored in digital format. Medical software provides appointment scheduling, patient registration, billing service as well as prescription of medicines via digital medium. Additionally, this software also aids in management of electronic health records to enhance interoperability and overall management process. It can also be utilized for securing clinical data, transmission of the data to healthcare organizations thus ensuring data exchange for updated services and solutions. Medical software has various advantages right from improvising the administration functioning and keeping a track of patients, cases, medical inventory to healthcare service management and ensuring government compliance.

COVID – 19 scenario analysis:  

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
  • Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to medical software has been reduced and this segment have to face negligence subsequently causing negative impact on medical software market
  • However, various advantages with use of medical software would be helpful in the rise of this pandemic and facilitate healthcare services management which is increasingly important in this pandemic time

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The growing consumer demand for personalization in healthcare services, rising need for remote monitoring services owing to rise in cases of chronic diseases, deep penetration software’s and platforms providing track of health and access to medical information among healthcare practitioners and physicians are the prime factors driving the market growth.

In addition to this, the rise in patient pool with chronic conditions, immense costs of efficient therapeutic treatments and diagnostics, high life expectancy, consumer demand for superior quality of life and the World Health Organization estimations regarding worldwide shortage of around 4.3 million health workers are other major factors propelling the growth of digital health market. 

At the same time, technological advents with an increasingly high pace especially in the software field is revolutionizing is healthcare industry. Affordable and speedy internet access, deep healthcare software penetration coupled with advanced technologies such as artificial intelligence, genomics, telemedicine in the medical field are transforming the healthcare industry. Similarly, abundant innovations in the software component has propelled the medical software market pertaining to tremendous amount of medical data and records, accessibility to clinical information, development of decision making support systems, peer support and open access clinical studies and guidelines. This has led to increase in adoption of medical software services globally which would further ensure market development.

On the contrary, lack of awareness among people regarding medical software, scarcity of skilled IT professionals especially in developing and underdeveloped regions, high costs related to maintenance and installation are some of the factors that might hamper the growth of medical software market growth. 

Technological advancements to boost the growth

Technological developments in the health IT industry for developing innovative digitalized healthcare solutions with integration of advanced information technology would fuel the growth of medical software market.  This is due to increasing need for medical software’s and management platforms, increasing adoption of IT solutions in healthcare industry and the growing usage of electronic health records. Furthermore, enormous efforts put forth by various market players in research and development activities emphasizing on development of efficient and affordable healthcare software’s would surge the demand for medical software’s. For instance, healthcare IT firm CureMD joined forces with National Comprehensive Cancer Network (NCCN) for development of oncology specific template and its integration into EHR software. 

Credible, a leading medical software company introduced the EHR Best Practices Community in association with the human service and health provider OPEN MINDS. This provides a platform to online community for betterment of the quality of care offered in medical field. Such technological advancements in IT health solutions and launch of innovative products in the market will positively impact the medical software market ensuring immense growth over the coming years.

North American segment to have dominance in the market with highest market share

North America is expected to have significant growth in the market and holds highest market share in the regional segments. The dominance is due to factors like higher adoption of technology in the region resulting for higher demand for innovative management technologies is propelling the market in the United States. Drastic rise in healthcare expenditure and high strain to achieve better health outputs at lower costs, availability of a well-developed infrastructure, presence of major industry and government initiatives to induce medical software solutions in the healthcare settings are the other factors fostering the market growth in the near future.

Key benefits of the report:

  • This study presents the analytical depiction of the global medical software market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global medical software market share.
  • The current market is quantitatively analyzed to highlight the global market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global medical software market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Medical software Market research report:

  • What are the leading market players active in the medical software market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Key Market Segments

  • By Delivery mode
    • On-premises
    • Cloud-based
  • By Services
    • Client Relationship Management (CRM)
    • Electronic Medical Records (EMR)
    • Electronic Health Records (EHR)
    • Medical Practice Management
    • Telemedicine
    • Population Health Management
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Philips,
  • NXGN Management
  • eClinicalWorks,
  • Allscripts Healthcare,
  • Siemens Healthcare,
  • First Databank,
  • Updox,
  • McKesson Corporation,
  • GE Healthcare,
  • IBM,
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: MEDICAL SOFTWARE MARKET, BY DELIVERY MODE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Delivery Mode

    • 4.2. On-premises

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Cloud-based

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: MEDICAL SOFTWARE MARKET, BY SERVICES

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Services

    • 5.2. Client Relationship Management (CRM)

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Electronic Medical Records (EMR)

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Electronic Health Records (EHR)

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Medical Practice Management

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Telemedicine

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Population Health Management

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Others

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

  • CHAPTER 6: MEDICAL SOFTWARE MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Others

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: MEDICAL SOFTWARE MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Delivery Mode

      • 7.2.3. Market Size and Forecast, By Services

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Medical Software Market

        • 7.2.6.1. Market Size and Forecast, By Delivery Mode
        • 7.2.6.2. Market Size and Forecast, By Services
        • 7.2.6.3. Market Size and Forecast, By End User
      • 7.2.7. Canada Medical Software Market

        • 7.2.7.1. Market Size and Forecast, By Delivery Mode
        • 7.2.7.2. Market Size and Forecast, By Services
        • 7.2.7.3. Market Size and Forecast, By End User
      • 7.2.8. Mexico Medical Software Market

        • 7.2.8.1. Market Size and Forecast, By Delivery Mode
        • 7.2.8.2. Market Size and Forecast, By Services
        • 7.2.8.3. Market Size and Forecast, By End User
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Delivery Mode

      • 7.3.3. Market Size and Forecast, By Services

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Medical Software Market

        • 7.3.6.1. Market Size and Forecast, By Delivery Mode
        • 7.3.6.2. Market Size and Forecast, By Services
        • 7.3.6.3. Market Size and Forecast, By End User
      • 7.3.7. Germany Medical Software Market

        • 7.3.7.1. Market Size and Forecast, By Delivery Mode
        • 7.3.7.2. Market Size and Forecast, By Services
        • 7.3.7.3. Market Size and Forecast, By End User
      • 7.3.8. Italy Medical Software Market

        • 7.3.8.1. Market Size and Forecast, By Delivery Mode
        • 7.3.8.2. Market Size and Forecast, By Services
        • 7.3.8.3. Market Size and Forecast, By End User
      • 7.3.9. Spain Medical Software Market

        • 7.3.9.1. Market Size and Forecast, By Delivery Mode
        • 7.3.9.2. Market Size and Forecast, By Services
        • 7.3.9.3. Market Size and Forecast, By End User
      • 7.3.10. UK Medical Software Market

        • 7.3.10.1. Market Size and Forecast, By Delivery Mode
        • 7.3.10.2. Market Size and Forecast, By Services
        • 7.3.10.3. Market Size and Forecast, By End User
      • 7.3.11. Russia Medical Software Market

        • 7.3.11.1. Market Size and Forecast, By Delivery Mode
        • 7.3.11.2. Market Size and Forecast, By Services
        • 7.3.11.3. Market Size and Forecast, By End User
      • 7.3.12. Rest Of Europe Medical Software Market

        • 7.3.12.1. Market Size and Forecast, By Delivery Mode
        • 7.3.12.2. Market Size and Forecast, By Services
        • 7.3.12.3. Market Size and Forecast, By End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Delivery Mode

      • 7.4.3. Market Size and Forecast, By Services

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Medical Software Market

        • 7.4.6.1. Market Size and Forecast, By Delivery Mode
        • 7.4.6.2. Market Size and Forecast, By Services
        • 7.4.6.3. Market Size and Forecast, By End User
      • 7.4.7. Japan Medical Software Market

        • 7.4.7.1. Market Size and Forecast, By Delivery Mode
        • 7.4.7.2. Market Size and Forecast, By Services
        • 7.4.7.3. Market Size and Forecast, By End User
      • 7.4.8. India Medical Software Market

        • 7.4.8.1. Market Size and Forecast, By Delivery Mode
        • 7.4.8.2. Market Size and Forecast, By Services
        • 7.4.8.3. Market Size and Forecast, By End User
      • 7.4.9. South Korea Medical Software Market

        • 7.4.9.1. Market Size and Forecast, By Delivery Mode
        • 7.4.9.2. Market Size and Forecast, By Services
        • 7.4.9.3. Market Size and Forecast, By End User
      • 7.4.10. Australia Medical Software Market

        • 7.4.10.1. Market Size and Forecast, By Delivery Mode
        • 7.4.10.2. Market Size and Forecast, By Services
        • 7.4.10.3. Market Size and Forecast, By End User
      • 7.4.11. Thailand Medical Software Market

        • 7.4.11.1. Market Size and Forecast, By Delivery Mode
        • 7.4.11.2. Market Size and Forecast, By Services
        • 7.4.11.3. Market Size and Forecast, By End User
      • 7.4.12. Malaysia Medical Software Market

        • 7.4.12.1. Market Size and Forecast, By Delivery Mode
        • 7.4.12.2. Market Size and Forecast, By Services
        • 7.4.12.3. Market Size and Forecast, By End User
      • 7.4.13. Indonesia Medical Software Market

        • 7.4.13.1. Market Size and Forecast, By Delivery Mode
        • 7.4.13.2. Market Size and Forecast, By Services
        • 7.4.13.3. Market Size and Forecast, By End User
      • 7.4.14. Rest of Asia Pacific Medical Software Market

        • 7.4.14.1. Market Size and Forecast, By Delivery Mode
        • 7.4.14.2. Market Size and Forecast, By Services
        • 7.4.14.3. Market Size and Forecast, By End User
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Delivery Mode

      • 7.5.3. Market Size and Forecast, By Services

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Medical Software Market

        • 7.5.6.1. Market Size and Forecast, By Delivery Mode
        • 7.5.6.2. Market Size and Forecast, By Services
        • 7.5.6.3. Market Size and Forecast, By End User
      • 7.5.7. South Africa Medical Software Market

        • 7.5.7.1. Market Size and Forecast, By Delivery Mode
        • 7.5.7.2. Market Size and Forecast, By Services
        • 7.5.7.3. Market Size and Forecast, By End User
      • 7.5.8. Saudi Arabia Medical Software Market

        • 7.5.8.1. Market Size and Forecast, By Delivery Mode
        • 7.5.8.2. Market Size and Forecast, By Services
        • 7.5.8.3. Market Size and Forecast, By End User
      • 7.5.9. UAE Medical Software Market

        • 7.5.9.1. Market Size and Forecast, By Delivery Mode
        • 7.5.9.2. Market Size and Forecast, By Services
        • 7.5.9.3. Market Size and Forecast, By End User
      • 7.5.10. Argentina Medical Software Market

        • 7.5.10.1. Market Size and Forecast, By Delivery Mode
        • 7.5.10.2. Market Size and Forecast, By Services
        • 7.5.10.3. Market Size and Forecast, By End User
      • 7.5.11. Rest of LAMEA Medical Software Market

        • 7.5.11.1. Market Size and Forecast, By Delivery Mode
        • 7.5.11.2. Market Size and Forecast, By Services
        • 7.5.11.3. Market Size and Forecast, By End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Allscripts Healthcare,

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. EClinicalWorks,

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. First Databank,

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Siemens Healthcare,

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Updox,

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. GE Healthcare,

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. IBM,

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Philips,

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. McKesson Corporation,

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. NXGN Management

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL SOFTWARE MARKET, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL MEDICAL SOFTWARE MARKET FOR ON-PREMISES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL MEDICAL SOFTWARE MARKET FOR CLOUD-BASED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL MEDICAL SOFTWARE MARKET, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL MEDICAL SOFTWARE MARKET FOR CLIENT RELATIONSHIP MANAGEMENT (CRM), BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL MEDICAL SOFTWARE MARKET FOR ELECTRONIC MEDICAL RECORDS (EMR), BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL MEDICAL SOFTWARE MARKET FOR ELECTRONIC HEALTH RECORDS (EHR), BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL MEDICAL SOFTWARE MARKET FOR MEDICAL PRACTICE MANAGEMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL MEDICAL SOFTWARE MARKET FOR TELEMEDICINE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL MEDICAL SOFTWARE MARKET FOR POPULATION HEALTH MANAGEMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL MEDICAL SOFTWARE MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL MEDICAL SOFTWARE MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL MEDICAL SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL MEDICAL SOFTWARE MARKET FOR CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL MEDICAL SOFTWARE MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL MEDICAL SOFTWARE MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA MEDICAL SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. U.S. MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 22. U.S. MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 23. U.S. MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. CANADA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 25. CANADA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 26. CANADA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 29. MEXICO MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE MEDICAL SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 33. EUROPE MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 36. FRANCE MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 39. GERMANY MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. ITALY MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 41. ITALY MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 42. ITALY MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 45. SPAIN MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. UK MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 47. UK MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 48. UK MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 51. RUSSIA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 54. REST OF EUROPE MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC MEDICAL SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 58. ASIA-PACIFIC MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. CHINA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 60. CHINA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 61. CHINA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 64. JAPAN MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. INDIA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 66. INDIA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 67. INDIA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 70. SOUTH KOREA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 73. AUSTRALIA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 76. THAILAND MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 79. MALAYSIA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 82. INDONESIA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA MEDICAL SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 89. LAMEA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 92. BRAZIL MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 95. SOUTH AFRICA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 98. SAUDI ARABIA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 99. UAE MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 100. UAE MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 101. UAE MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 104. ARGENTINA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA MEDICAL SOFTWARE, BY DELIVERY MODE, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA MEDICAL SOFTWARE, BY SERVICES, 2025-2033 ($MILLION)
  • TABLE 107. REST OF LAMEA MEDICAL SOFTWARE, BY END USER, 2025-2033 ($MILLION)
  • TABLE 108. ALLSCRIPTS HEALTHCARE,: KEY EXECUTIVES
  • TABLE 109. ALLSCRIPTS HEALTHCARE,: COMPANY SNAPSHOT
  • TABLE 110. ALLSCRIPTS HEALTHCARE,: OPERATING SEGMENTS
  • TABLE 111. ALLSCRIPTS HEALTHCARE,: PRODUCT PORTFOLIO
  • TABLE 112. ALLSCRIPTS HEALTHCARE,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. ECLINICALWORKS,: KEY EXECUTIVES
  • TABLE 114. ECLINICALWORKS,: COMPANY SNAPSHOT
  • TABLE 115. ECLINICALWORKS,: OPERATING SEGMENTS
  • TABLE 116. ECLINICALWORKS,: PRODUCT PORTFOLIO
  • TABLE 117. ECLINICALWORKS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. FIRST DATABANK,: KEY EXECUTIVES
  • TABLE 119. FIRST DATABANK,: COMPANY SNAPSHOT
  • TABLE 120. FIRST DATABANK,: OPERATING SEGMENTS
  • TABLE 121. FIRST DATABANK,: PRODUCT PORTFOLIO
  • TABLE 122. FIRST DATABANK,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. SIEMENS HEALTHCARE,: KEY EXECUTIVES
  • TABLE 124. SIEMENS HEALTHCARE,: COMPANY SNAPSHOT
  • TABLE 125. SIEMENS HEALTHCARE,: OPERATING SEGMENTS
  • TABLE 126. SIEMENS HEALTHCARE,: PRODUCT PORTFOLIO
  • TABLE 127. SIEMENS HEALTHCARE,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. UPDOX,: KEY EXECUTIVES
  • TABLE 129. UPDOX,: COMPANY SNAPSHOT
  • TABLE 130. UPDOX,: OPERATING SEGMENTS
  • TABLE 131. UPDOX,: PRODUCT PORTFOLIO
  • TABLE 132. UPDOX,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. GE HEALTHCARE,: KEY EXECUTIVES
  • TABLE 134. GE HEALTHCARE,: COMPANY SNAPSHOT
  • TABLE 135. GE HEALTHCARE,: OPERATING SEGMENTS
  • TABLE 136. GE HEALTHCARE,: PRODUCT PORTFOLIO
  • TABLE 137. GE HEALTHCARE,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. IBM,: KEY EXECUTIVES
  • TABLE 139. IBM,: COMPANY SNAPSHOT
  • TABLE 140. IBM,: OPERATING SEGMENTS
  • TABLE 141. IBM,: PRODUCT PORTFOLIO
  • TABLE 142. IBM,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. PHILIPS,: KEY EXECUTIVES
  • TABLE 144. PHILIPS,: COMPANY SNAPSHOT
  • TABLE 145. PHILIPS,: OPERATING SEGMENTS
  • TABLE 146. PHILIPS,: PRODUCT PORTFOLIO
  • TABLE 147. PHILIPS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. MCKESSON CORPORATION,: KEY EXECUTIVES
  • TABLE 149. MCKESSON CORPORATION,: COMPANY SNAPSHOT
  • TABLE 150. MCKESSON CORPORATION,: OPERATING SEGMENTS
  • TABLE 151. MCKESSON CORPORATION,: PRODUCT PORTFOLIO
  • TABLE 152. MCKESSON CORPORATION,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 153. NXGN MANAGEMENT: KEY EXECUTIVES
  • TABLE 154. NXGN MANAGEMENT: COMPANY SNAPSHOT
  • TABLE 155. NXGN MANAGEMENT: OPERATING SEGMENTS
  • TABLE 156. NXGN MANAGEMENT: PRODUCT PORTFOLIO
  • TABLE 157. NXGN MANAGEMENT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL SOFTWARE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MEDICAL SOFTWARE MARKET
  • FIGURE 3. SEGMENTATION MEDICAL SOFTWARE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MEDICAL SOFTWARE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMEDICAL SOFTWARE MARKET
  • FIGURE 11. MEDICAL SOFTWARE MARKET SEGMENTATION, BY BY DELIVERY MODE
  • FIGURE 12. MEDICAL SOFTWARE MARKET FOR ON-PREMISES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. MEDICAL SOFTWARE MARKET FOR CLOUD-BASED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. MEDICAL SOFTWARE MARKET SEGMENTATION, BY BY SERVICES
  • FIGURE 15. MEDICAL SOFTWARE MARKET FOR CLIENT RELATIONSHIP MANAGEMENT (CRM), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. MEDICAL SOFTWARE MARKET FOR ELECTRONIC MEDICAL RECORDS (EMR), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. MEDICAL SOFTWARE MARKET FOR ELECTRONIC HEALTH RECORDS (EHR), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. MEDICAL SOFTWARE MARKET FOR MEDICAL PRACTICE MANAGEMENT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. MEDICAL SOFTWARE MARKET FOR TELEMEDICINE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. MEDICAL SOFTWARE MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. MEDICAL SOFTWARE MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. MEDICAL SOFTWARE MARKET SEGMENTATION, BY BY END USER
  • FIGURE 23. MEDICAL SOFTWARE MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. MEDICAL SOFTWARE MARKET FOR CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. MEDICAL SOFTWARE MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: MEDICAL SOFTWARE MARKET
  • FIGURE 32. TOP PLAYER POSITIONING, 2024
  • FIGURE 33. ALLSCRIPTS HEALTHCARE,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. ALLSCRIPTS HEALTHCARE,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. ALLSCRIPTS HEALTHCARE,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. ECLINICALWORKS,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. ECLINICALWORKS,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. ECLINICALWORKS,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. FIRST DATABANK,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. FIRST DATABANK,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. FIRST DATABANK,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. SIEMENS HEALTHCARE,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. SIEMENS HEALTHCARE,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. SIEMENS HEALTHCARE,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. UPDOX,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. UPDOX,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. UPDOX,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. GE HEALTHCARE,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. GE HEALTHCARE,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. GE HEALTHCARE,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. IBM,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. IBM,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. IBM,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. PHILIPS,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. PHILIPS,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. PHILIPS,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. MCKESSON CORPORATION,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. MCKESSON CORPORATION,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. MCKESSON CORPORATION,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 60. NXGN MANAGEMENT: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 61. NXGN MANAGEMENT: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 62. NXGN MANAGEMENT: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Medical Software Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue